BioDelivery Sciences International, Inc.
BDSI · NASDAQ
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Market Cap | $308 | $356 | $354 | $395 |
| - Cash | $114 | $101 | $120 | $116 |
| + Debt | $59 | $59 | $79 | $79 |
| Enterprise Value | $252 | $314 | $312 | $357 |
| Revenue | $43 | $41 | $41 | $41 |
| % Growth | 5% | -0.8% | 1% | – |
| Gross Profit | $36 | $35 | $37 | $35 |
| % Margin | 84% | 84.5% | 89.7% | 85.8% |
| EBITDA | $11 | $11 | $13 | $9 |
| % Margin | 25.7% | 27% | 31.7% | 22.4% |
| Net Income | $64 | $7 | $9 | $5 |
| % Margin | 148.1% | 16.2% | 21.9% | 12.8% |
| EPS Diluted | 0.61 | 0.07 | 0.09 | 0.05 |
| % Growth | 771.4% | -22.2% | 80% | – |
| Operating Cash Flow | $14 | $7 | $9 | $11 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | $14 | $7 | $9 | $11 |